Early buyers will receive 10% customization on reports.
Pressure monitoring market offers a favorable approach for monitoring of various kinds of pressures in the different parts of the body. Pressure monitoring plays an important role in detecting the health problems of a patient.
The major fluctuations of pressure in the vital areas of the body may cause various chronic and acute diseases such as diabetes, cardiac arrest, and glaucoma.
The report segments the pressure monitoring market on the basis of product type, procedure, therapeutic application, end user, and geography.
On the product type, pressure monitoring devices segment is expected to account for the largest share in 2015, closely followed by the pressure monitoring accessories segment.
The pressure monitoring device segment is further segmented into blood pressure monitoring devices, intraocular pressure monitoring devices, intracranial pressure monitoring devices. The blood pressure monitoring devices segment is expected to grow at the highest CAGR during the forecast period, owing to increasing prevalence of hypertension, increasing use of non-invasive devices, and patient compliance.
On the basis of end user, the pressure monitoring market is segmented into hospitals, ASCs/clinics, home care settings, diagnostic centers and other end users.
Geographically, the market is dominated by North America, followed by Europe. North America is expected to account for the largest share of the pressure monitoring market in 2015, with Asia having the highest growth rate during the forecast period.
Key players in the pressure monitoring market include Philips Healthcare (The Netherlands), GE Healthcare (U.K.), Welch Allyn, Inc. (U.S.), Medtronic (U.S.), and Drägerwerk AG & Co. KGaA (Germany).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
